Skip to search formSkip to main contentSkip to account menu

Fansimef

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

mefloquine-sulfadoxine-pyrimethamine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Mefloquine insusceptibility of malaria in Thailand not promoted by nonregulated drug-use.
1993
1993
Mefloquine monitoring in acute uncomplicated malaria treated with Fansimef and Lariam.
Mefloquine levels were compared between Plasmodium falciparum malaria patients with sensitive response and those with treatment… 
1990
1990
Phase III double-blind comparative study of Fansimef and Lariam for the curative treatment of Plasmodium falciparum infections in Thailand.
A double-blind comparative study of Fanismef-mefloquine/sulfadoxine/pyrimethamine (MSP) and Lariam-mefloquine (MEF) for the… 
1990
1990
Pharmacokinetics of the combination pyrimethamine with sulfadoxine and mefloquine (FANSIMEF) in Chinese volunteers and the relative bioavailability of a lacquered tablet.
The oral single-dose pharmacokinetics and bioavailability of mefloquine (M) in combination with pyrimethamine (P) and sulfadoxine… 
1989
1989
Single dose kinetic study of the triple combination mefloquine/sulphadoxine/pyrimethamine (Fansimef) in healthy male volunteers.
A single dose pharmacokinetic study of a combined antimalarial formulation of mefloquine, sulphadoxine and pyrimethamine… 
1989
1989
Simultaneous determination of pyrimethamine and mefloquine in human plasma by high-performance liquid chromatography with ultraviolet detection.
1988
1988
Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
1987
1987
Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
Fansimef is a new oral schizonticide which contains pyrimethamine (P), sulfadoxine (S) and mefloquine (M) in a weight ratio of 1… 
1987
1987
Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects.
Fansimef is a new antimalarial combination containing pyrimethamine, sulfadoxine and mefloquine in the weight proportions 1 + 20… 
1987
1987
A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
Fansimef is a combination of 250 mg mefloquine (base), 500 mg sulfadoxine, and 25 mg pyrimethamine per tablet. One hundred and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)